Operating Margin in % of Nabriva Therapeutics plc from 2016 to Q2 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Nabriva Therapeutics plc quarterly/annual Operating Margin history and change rate from 2016 to Q2 2023.
  • Nabriva Therapeutics plc Operating Margin for the quarter ending 30 Jun 2023 was -183 %, a 41.5% decline year-over-year.
  • Nabriva Therapeutics plc annual Operating Margin for 2022 was -150 %, a 10.5% increase from 2021.
  • Nabriva Therapeutics plc annual Operating Margin for 2021 was -168 %, a 87.2% increase from 2020.
  • Nabriva Therapeutics plc annual Operating Margin for 2020 was -1.32K %, a 56.9% decline from 2019.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Nabriva Therapeutics plc Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2023 -183 -53.6 -41.5% 01 Apr 2023 30 Jun 2023
Q1 2023 -144 -7.93 -5.85% 01 Jan 2023 31 Mar 2023
Q4 2022 -150 +17.7 +10.5% 01 Oct 2022 31 Dec 2022
Q3 2022 -129 +115 +47% 01 Jul 2022 30 Sep 2022
Q2 2022 -129 +259 +66.7% 01 Apr 2022 30 Jun 2022
Q1 2022 -136 +742 +84.5% 01 Jan 2022 31 Mar 2022
Q4 2021 -168 +1.15K +87.2% 01 Oct 2021 31 Dec 2021
Q3 2021 -244 +2.17K +89.9% 01 Jul 2021 30 Sep 2021
Q2 2021 -388 +479 +55.3% 01 Apr 2021 30 Jun 2021
Q1 2021 -878 +61.3 +6.53% 01 Jan 2021 31 Mar 2021
Q4 2020 -1.32K -477 -56.9% 01 Oct 2020 31 Dec 2020
Q3 2020 -2.41K -1.52K -172% 01 Jul 2020 30 Sep 2020
Q2 2020 -867 +2.69K +75.6% 01 Apr 2020 30 Jun 2020
Q1 2020 -939 +2.23K +70.4% 01 Jan 2020 31 Mar 2020
Q4 2019 -838 +346 +29.2% 01 Oct 2019 31 Dec 2019
Q3 2019 -888 +172 +16.2% 01 Jul 2019 30 Sep 2019
Q2 2019 -3.56K -2.89K -431% 01 Apr 2019 30 Jun 2019
Q1 2019 -3.17K -2.53K -397% 01 Jan 2019 31 Mar 2019
Q4 2018 -1.18K +202 +14.6% 01 Oct 2018 31 Dec 2018
Q3 2018 -1.06K 01 Jul 2018 30 Sep 2018
Q2 2018 -670 01 Apr 2018 30 Jun 2018
Q1 2018 -638 01 Jan 2018 31 Mar 2018
Q4 2017 -1.39K 01 Oct 2017 31 Dec 2017

Nabriva Therapeutics plc Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2022 -150 +17.7 +10.5% 01 Jan 2022 31 Dec 2022
2021 -168 +1.15K +87.2% 01 Jan 2021 31 Dec 2021
2020 -1.32K -477 -56.9% 01 Jan 2020 31 Dec 2020
2019 -838 +346 +29.2% 01 Jan 2019 31 Dec 2019
2018 -1.18K +202 +14.6% 01 Jan 2018 31 Dec 2018
2017 -1.39K -538 -63.3% 01 Jan 2017 31 Dec 2017
2016 -849 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.